142 related articles for article (PubMed ID: 37059391)
1. The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non-Small Cell Lung Cancer.
Jones M; Lowin J; Sewell B; Gemine RE; Rees SE; Lanyon K; Lewis KE
Value Health; 2023 Aug; 26(8):1192-1200. PubMed ID: 37059391
[TBL] [Abstract][Full Text] [Related]
2. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.
Villanti AC; Jiang Y; Abrams DB; Pyenson BS
PLoS One; 2013; 8(8):e71379. PubMed ID: 23940744
[TBL] [Abstract][Full Text] [Related]
3. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
5. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
[TBL] [Abstract][Full Text] [Related]
8. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study.
Cadham CJ; Cao P; Jayasekera J; Taylor KL; Levy DT; Jeon J; Elkin EB; Foley KL; Joseph A; Kong CY; Minnix JA; Rigotti NA; Toll BA; Zeliadt SB; Meza R; Mandelblatt J;
J Natl Cancer Inst; 2021 Aug; 113(8):1065-1073. PubMed ID: 33484569
[TBL] [Abstract][Full Text] [Related]
10. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial.
Wu Q; Gilbert H; Nazareth I; Sutton S; Morris R; Petersen I; Galton S; Parrott S
Addiction; 2018 Apr; 113(4):708-718. PubMed ID: 29105871
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study.
Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S;
Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness, Cost-effectiveness, and Cost-Utility of a Digital Smoking Cessation Intervention for Cancer Survivors: Health Economic Evaluation and Outcomes of a Pragmatic Randomized Controlled Trial.
Mujcic A; Blankers M; Boon B; Verdonck-de Leeuw IM; Smit F; van Laar M; Engels R
J Med Internet Res; 2022 Mar; 24(3):e27588. PubMed ID: 35297777
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer.
Slatore CG; Au DH; Hollingworth W
J Thorac Oncol; 2009 Apr; 4(4):499-504. PubMed ID: 19204575
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.
Daly AT; Deshmukh AA; Vidrine DJ; Prokhorov AV; Frank SG; Tahay PD; Houchen ME; Cantor SB
Tob Control; 2019 Jan; 28(1):88-94. PubMed ID: 29886411
[TBL] [Abstract][Full Text] [Related]
17. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Keating GM; Lyseng-Williamson KA
Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
[TBL] [Abstract][Full Text] [Related]
18. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
